Immatics (IMTX) Return on Equity (2021 - 2025)

Immatics recorded quarterly Return on Equity of 0.0% in Q4 2025, up 7.66% quarter-over-quarter from 0.0% in Q3 2025, and little changed year-over-year from 0.0% in Q4 2024.

Immatics' Return on Equity history runs 5 years deep, the most recent figure standing at 0.0% for Q4 2025.

  • In Q4 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
  • Return on Equity came in at 0.0% for Q4 2025 at Immatics, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2022 to a low of 0.03% in Q2 2021.
  • A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Equity.
  • Across the five-year window, Return on Equity climbed 4 bps in 2022 and retreated 1 bps in 2023, its largest moves.
  • Immatics' Return on Equity stood at 0.03% in 2021, then jumped by 113 bps to 0.0% in 2022, then slumped by 196 bps to 0.0% in 2023, then surged by 117 bps to 0.0% in 2024, then slumped by 438 bps to 0.0% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -0.04%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -0.01%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.00%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 0.01%
10 Immatics 1.80 Bn 1.80 Bn - 0.00%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 -0.03%
Sep 30, 2021 -0.02%
Jun 30, 2021 -0.03%
Mar 31, 2021 -0.01%